A study has identified a new possible drug target to treat osteosarcoma. The research is in its early stages but it shows that our understanding of osteosarcoma is increasing.

Applications are now open to join our patient advisory board. We are looking for 6 members of the osteosarcoma community to join our board and help direct our charity’s work.

Primary bone cancerA disease where cells divide and grow uncontrollably and can spread to other areas of the body. (PBC) is a group of cancers that includes osteosarcoma (OS). Other cancers in this group are Ewing’s sarcoma, chondrosarcoma and chordoma. There have been few advances in the treatment of PBC for the past 40 years. This means there is an urgent...

A recent study explored a potential treatment called APR-246 in hard-to-treat cancers containing specific genetic mutations.

This week Kate Quillin, Research Officer at Sarcoma UK, took over our blog. Sarcoma UK fund vital research, offer support and campaign for better treatments.

We are excited to announce that the first Osteosarcoma Now Newsletter (ONN) will be in your inbox on Friday 30th September. Sign up now!

Understanding how osteosarcoma spreads could help future treatment strategies. Last year, a paper was published identifying a role for a proteinFound in cells and needed for the development, growth and function of our bodies. called P2RX7B in promoting growth and spread of osteosarcoma.

Dr Strauss is one of the UK’s leading researchers in osteosarcoma and is leading the ICONIC trial. We were delighted to interview her about the importance of the study, how to get involved and the results so far.

We attended the MIB Agents FACTOR conference. The osteosarcoma community joined forces for an inspirational cause – to make things better.

Two trials have been published looking at new treatments in osteosarcoma. Although the drugs were not effective there is a lot that can be learned from them.